{"schema_version":"secwatch.filing_event.v1","accession":"0000096943-24-000128","form_type":"8-K","ticker":"TFX","cik":"0000096943","company_name":"TELEFLEX INC","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.485745+00:00","generated_at":"2026-05-31T14:12:34.850686+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Teleflex Q2 adjusted revenue $763.5M (+2.7%); raises FY adj EPS guidance to $13.80-$14.20","bullets":["GAAP revenue $749.7M (+0.9% YoY); adjusted revenue $763.5M (+2.7% YoY, +3.4% constant currency).","GAAP diluted EPS $1.69 vs $2.35 prior; adjusted diluted EPS $3.42 vs $3.41 prior.","Raises FY adjusted constant currency revenue growth guidance to 4.25%-5.25%; lowers GAAP EPS guidance to $6.43-$6.83.","Board authorized $500M share repurchase program, including $200M accelerated share repurchase.","CEO cites strong Barrigel momentum and Palette Life Sciences integration on track."],"urls":{"canonical":"https://secwatch.observer/filing/0000096943-24-000128","json":"https://secwatch.observer/filing/0000096943-24-000128.json","markdown":"https://secwatch.observer/filing/0000096943-24-000128.md","text":"https://secwatch.observer/filing/0000096943-24-000128.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/96943/000009694324000128/0000096943-24-000128-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/96943/000009694324000128/tfx-20240801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:12:34.850686+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}